These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28945804)

  • 1. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.
    Radzikowska E; Wiatr E; Langfort R; Bestry I; Skoczylas A; Szczepulska-Wójcik E; Gawryluk D; Rudziński P; Chorostowska-Wynimko J; Roszkowski-Śliż K
    PLoS One; 2017; 12(9):e0184739. PubMed ID: 28945804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Organizing pneumonia--clarithromycin treatment].
    Radzikowska E; Wiatr E; Gawryluk D; Langfort R; Bestry I; Chabowski M; Roszkowski K
    Pneumonol Alergol Pol; 2008; 76(5):334-9. PubMed ID: 19003763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of three patients with organizing pneumonia associated with rheumatoid arthritis using clarithromycin and prednisolone.
    Ohe M; Shida H; Horita T; Ito K; Sugiura M; Hattori A; Oku K
    Drug Discov Ther; 2017; 11(4):218-222. PubMed ID: 28867755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia.
    Zhou Y; Wang L; Huang M; Ding J; Jiang H; Zhou K; Meng F; Xiao Y; Cai H; Dai J
    Chron Respir Dis; 2019; 16():1479973119853829. PubMed ID: 31159568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia.
    Pathak V; Kuhn JM; Durham C; Funkhouser WK; Henke DC
    Ann Am Thorac Soc; 2014 Jan; 11(1):87-91. PubMed ID: 24460438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin Decreases IL-6 Concentration in Serum and BAL Fluid in Patients with Cryptogenic Organizing Pneumonia.
    Radzikowska E; Roży A; Jagus P; Polubiec-Kownacka M; Wiatr E; Chorostowska-Wynimko J; Roszkowski-Śliż K
    Adv Clin Exp Med; 2016; 25(5):871-878. PubMed ID: 28028949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment.
    Radzikowska E; Roży A; Jaguś P; Wiatr E; Gawryluk D; Chorostowska-Wynimko J; Roszkowski-Śliż K
    Adv Exp Med Biol; 2016; 911():77-85. PubMed ID: 26987326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organizing pneumonia--analysis of 18 own cases].
    Radzikowska E; Wiatr E; Remiszewski P; Bestry I; Grudny J; Langfort R; Szopiński J; Zych J; Płodziszewska M; Rudziński P; Gawryluk D; Roszkowska B; Roszkowski K
    Pneumonol Alergol Pol; 2004; 72(3-4):99-104. PubMed ID: 15757271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful salvage treatment of steroid-refractory bronchiolar COP with low-dose macrolides.
    Chang WJ; Lee EJ; Lee SY; In KH; Kim CH; Kim HK; Park S
    Pathol Int; 2012 Feb; 62(2):144-8. PubMed ID: 22243785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia.
    Yoo JW; Song JW; Jang SJ; Lee CK; Kim MY; Lee HK; Jegal Y; Kim DS
    Rheumatology (Oxford); 2011 May; 50(5):932-8. PubMed ID: 21169342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the relapse of cryptogenic and secondary organizing pneumonia.
    Onishi Y; Kawamura T; Nakahara Y; Kagami R; Sasaki S; Takahashi S; Kominami R; Hirano K; Hiraoka R; Hirata N
    Respir Investig; 2017 Jan; 55(1):10-15. PubMed ID: 28012487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 25 cases of biopsy-proven cryptogenic organizing pneumonia].
    Li HP; Fan F; Li QH; Zhao L; Li X; Yu H; Zhang RX; Yi XH; Shi JY; He GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Apr; 30(4):259-64. PubMed ID: 17651607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical manifestations of organizing pneumonia].
    Hunter M; Ludueña A; Telias I; Aruj P; Rausch S; Suárez JP
    Medicina (B Aires); 2016; 76(6):338-342. PubMed ID: 27959840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors.
    Yousem SA; Lohr RH; Colby TV
    Mod Pathol; 1997 Sep; 10(9):864-71. PubMed ID: 9310948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizing pneumonia.
    Drakopanagiotakis F; Polychronopoulos V; Judson MA
    Am J Med Sci; 2008 Jan; 335(1):34-9. PubMed ID: 18195581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia.
    Dong X; Zheng Y; Wang L; Chen WH; Zhang YG; Fu Q
    Clin Rheumatol; 2018 Apr; 37(4):1027-1035. PubMed ID: 28748510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia.
    Nishino M; Mathai SK; Schoenfeld D; Digumarthy SR; Kradin RL
    Hum Pathol; 2014 Feb; 45(2):342-51. PubMed ID: 24342432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptogenic organizing pneumonia in Sweet's syndrome: case report and review of the literature.
    Tzelepis E; Kampolis CF; Vlachadami I; Moschovi M; Alamani M; Kaltsas G
    Clin Respir J; 2016 Mar; 10(2):250-4. PubMed ID: 25196175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organizing pneumonia].
    Crestani B; Taillé C; Borie R; Debray MP; Danel C; Dombret MC; Aubier M
    Presse Med; 2010 Jan; 39(1):126-33. PubMed ID: 19945820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azithromycin as an adjuvant therapy in cryptogenic organizing pneumonia].
    Vaz AP; Morais A; Melo N; Caetano Mota P; Souto Moura C; Amorim A
    Rev Port Pneumol; 2011; 17(4):186-9. PubMed ID: 21652172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.